Actos (pioglitazone) is a prescription drug that’s used to help manage blood sugar levels in people with type 2 diabetes. Actos can cause side effects that range from mild to serious.

Both 15 mg and 30 mg pioglitazone doses have similar efficacy as 45 mg for preventing new-onset diabetes, stroke and myocardial infarction but with lower risk for adverse events, according to ...

Metformin/pioglitazone (Actoplus Met) is an oral drug used to treat type 2 diabetes. Learn about side effects, warnings, dosage, and more.

Review the side-effects of Pioglitazone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

In people with insulin resistance, prediabetes or diabetes, pioglitazone is associated with a decreased risk for major adverse cardiovascular events, study data show. However, pioglitazone may ...

Pioglitazone(Actos) generic is a thiazolidinedione antidiabetic, ... Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage.

In a study comparing the effects of pioglitazone and rosiglitazone, Goldberg and associates found that triglyceride levels of patients who were treated with pioglitazone decreased by 51.9 ± 7.8 ...

Dec. 13, 2004 -- Pioglitazone and metformin as monotherapy for type 2 diabetes are similarly effective in reducing hemoglobin A1c (HbA1c), but they have different effects on fasting plasma glucose ...

Pioglitazone is a potent insulin-sensitizing drug with anti-atherosclerotic properties, but adverse effects of weight gain and edema have limited its use. The researchers assessed the benefits and ...

There were 19 severe adverse events — 10 in the placebo ... Kleiner, DE, et al. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 2007;46:424-429.

Pioglitazone is a potent insulin-sensitizing drug with anti-atherosclerotic properties, but adverse effects of weight gain and edema have limited its use. The researchers assessed the benefits and ...